APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Anorexia-Cachexia Syndrome Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cancer Anorexia-Cachexia Syndrome Drug Industry Growth and Trends Forecast to 2032

19 December 2025103 pages

Choose your research edition.

Industry ResearchCancer Anorexia-Cachexia Syndrome Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Anorexia-Cachexia Syndrome Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cancer Anorexia-Cachexia Syndrome Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Anorexia-Cachexia Syndrome Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Anorexia-Cachexia Syndrome Drug Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cancer Anorexia-Cachexia Syndrome Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cancer Anorexia-Cachexia Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cancer Anorexia-Cachexia Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Anorexia-Cachexia Syndrome Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Anorexia-Cachexia Syndrome Drug include Novartis AG, Viking Therapeutics Inc, RaQualia Pharma Inc, PsiOxus Therapeutics Ltd, Obexia AG, Lakewood-Amedex Inc, Incyte Corp, Aphios Corp and Aeterna Zentaris Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cancer Anorexia-Cachexia Syndrome Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cancer Anorexia-Cachexia Syndrome Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cancer Anorexia-Cachexia Syndrome Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cancer Anorexia-Cachexia Syndrome Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cancer Anorexia-Cachexia Syndrome Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cancer Anorexia-Cachexia Syndrome Drug Market by Company

Novartis AG

Viking Therapeutics Inc

RaQualia Pharma Inc

PsiOxus Therapeutics Ltd

Obexia AG

Lakewood-Amedex Inc

Incyte Corp

Aphios Corp

Aeterna Zentaris Inc

Acacia Pharma Ltd

Cancer Anorexia-Cachexia Syndrome Drug Segment by Type

NEO-1940

Foxo1-nRNA

DLN-101

C-1889

AVGN-7

Others

Cancer Anorexia-Cachexia Syndrome Drug Segment by Application

Hospital

Clinic

Others

Cancer Anorexia-Cachexia Syndrome Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Anorexia-Cachexia Syndrome Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Anorexia-Cachexia Syndrome Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Anorexia-Cachexia Syndrome Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Anorexia-Cachexia Syndrome Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cancer Anorexia-Cachexia Syndrome Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of NEO-1940 Table 2. Major Company of Foxo1-nRNA Table 3. Major Company of DLN-101 Table 4. Major Company of C-1889 Table 5. Major Company of AVGN-7 Table 6. Major Company of Others Table 7. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 9. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type (2021-2026) Table 10. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 11. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type (2021-2026) Table 12. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2021-2026) & (US$/Unit) Table 13. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (K Units) Table 14. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type (2027-2032) Table 15. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2027-2032) & (US$ Million) Table 16. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type (2027-2032) Table 17. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Type (2027-2032) & (US$/Unit) Table 18. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 19. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 21. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 23. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 25. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (K Units) Table 27. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Type (2021-2026) & (US$ Million) Table 28. Cancer Anorexia-Cachexia Syndrome Drug Industry Trends Table 29. Cancer Anorexia-Cachexia Syndrome Drug Industry Drivers Table 30. Cancer Anorexia-Cachexia Syndrome Drug Industry Opportunities and Challenges Table 31. Cancer Anorexia-Cachexia Syndrome Drug Industry Restraints Table 32. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Cancer Anorexia-Cachexia Syndrome Drug Revenue Market Share by Company (2021-2026) Table 34. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Company (2021-2026) & (K Units) Table 35. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Company (2021-2026) Table 36. Global Cancer Anorexia-Cachexia Syndrome Drug Market Price by Company (2021-2026) & (US$/Unit) Table 37. Global Cancer Anorexia-Cachexia Syndrome Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Cancer Anorexia-Cachexia Syndrome Drug Major Company Production Sites and Headquarters Table 39. Global Cancer Anorexia-Cachexia Syndrome Drug Company, Product Type & Application Table 40. Global Cancer Anorexia-Cachexia Syndrome Drug Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Cancer Anorexia-Cachexia Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Region (2021-2026) Table 46. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2021-2026) & (US$ Million) Table 47. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Region (2021-2026) Table 48. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 49. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2027-2032) & (K Units) Table 50. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Region (2027-2032) Table 51. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Region (2027-2032) & (US$ Million) Table 52. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Region (2027-2032) Table 53. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 54. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 56. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application (2021-2026) Table 57. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 58. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application (2021-2026) Table 59. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2021-2026) & (US$/Unit) Table 60. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (K Units) Table 61. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application (2027-2032) Table 62. Global Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2027-2032) & (US$ Million) Table 63. Global Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application (2027-2032) Table 64. Global Cancer Anorexia-Cachexia Syndrome Drug Price by Application (2027-2032) & (US$/Unit) Table 65. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 66. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 68. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 70. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 72. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (K Units) Table 74. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Application (2021-2026) & (US$ Million) Table 75. Novartis AG Company Information Table 76. Novartis AG Business Overview Table 77. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 79. Novartis AG Recent Development Table 80. Viking Therapeutics Inc Company Information Table 81. Viking Therapeutics Inc Business Overview Table 82. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 84. Viking Therapeutics Inc Recent Development Table 85. RaQualia Pharma Inc Company Information Table 86. RaQualia Pharma Inc Business Overview Table 87. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 89. RaQualia Pharma Inc Recent Development Table 90. PsiOxus Therapeutics Ltd Company Information Table 91. PsiOxus Therapeutics Ltd Business Overview Table 92. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 94. PsiOxus Therapeutics Ltd Recent Development Table 95. Obexia AG Company Information Table 96. Obexia AG Business Overview Table 97. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 99. Obexia AG Recent Development Table 100. Lakewood-Amedex Inc Company Information Table 101. Lakewood-Amedex Inc Business Overview Table 102. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 104. Lakewood-Amedex Inc Recent Development Table 105. Incyte Corp Company Information Table 106. Incyte Corp Business Overview Table 107. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 109. Incyte Corp Recent Development Table 110. Aphios Corp Company Information Table 111. Aphios Corp Business Overview Table 112. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 114. Aphios Corp Recent Development Table 115. Aeterna Zentaris Inc Company Information Table 116. Aeterna Zentaris Inc Business Overview Table 117. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 119. Aeterna Zentaris Inc Recent Development Table 120. Acacia Pharma Ltd Company Information Table 121. Acacia Pharma Ltd Business Overview Table 122. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio Table 124. Acacia Pharma Ltd Recent Development Table 125. North America Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 126. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 127. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2026) Table 128. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032) & (K Units) Table 129. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 130. North America Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 131. North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 132. North America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country (2021-2026) Table 133. North America Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 134. North America Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Country (2027-2032) Table 135. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 136. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 137. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2026) Table 138. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032) & (K Units) Table 139. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 140. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 142. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country (2021-2026) Table 143. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Country (2027-2032) Table 145. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 146. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 147. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2026) Table 148. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032) & (K Units) Table 149. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 152. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country (2021-2026) Table 153. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Country (2027-2032) Table 155. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 156. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 157. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2026) Table 158. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032) & (K Units) Table 159. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 160. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 162. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country (2021-2026) Table 163. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Country (2027-2032) Table 165. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 166. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026) & (K Units) Table 167. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share by Country (2021-2026) Table 168. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032) & (K Units) Table 169. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026) & (US$ Million) Table 172. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country (2021-2026) Table 173. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Share Forecast by Country (2027-2032) Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Cancer Anorexia-Cachexia Syndrome Drug Distributors List Table 178. Cancer Anorexia-Cachexia Syndrome Drug Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Cancer Anorexia-Cachexia Syndrome Drug Image Figure 2. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Anorexia-Cachexia Syndrome Drug Sales (2021-2032) & (K Units) Figure 5. NEO-1940 Image Figure 6. Global NEO-1940 Sales YoY Growth (2021-2032) & (K Units) Figure 7. Foxo1-nRNA Image Figure 8. Global Foxo1-nRNA Sales YoY Growth (2021-2032) & (K Units) Figure 9. DLN-101 Image Figure 10. Global DLN-101 Sales YoY Growth (2021-2032) & (K Units) Figure 11. C-1889 Image Figure 12. Global C-1889 Sales YoY Growth (2021-2032) & (K Units) Figure 13. AVGN-7 Image Figure 14. Global AVGN-7 Sales YoY Growth (2021-2032) & (K Units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 17. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Type 2025 VS 2032 Figure 19. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 20. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 21. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 22. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 25. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Cancer Anorexia-Cachexia Syndrome Drug Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 33. Clinic Image Figure 34. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 37. Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Cancer Anorexia-Cachexia Syndrome Drug Market Share by Application 2025 VS 2032 Figure 39. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 40. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 41. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 42. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 45. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Market Share in Value by Application in 2025 Figure 49. North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. North America Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Latin America Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Cancer Anorexia-Cachexia Syndrome Drug Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Cancer Anorexia-Cachexia Syndrome Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • NEO-1940
  • Foxo1-nRNA
  • DLN-101
  • C-1889
  • AVGN-7
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Novartis AG
  • Viking Therapeutics Inc
  • RaQualia Pharma Inc
  • PsiOxus Therapeutics Ltd
  • Obexia AG
  • Lakewood-Amedex Inc
  • Incyte Corp
  • Aphios Corp
  • Aeterna Zentaris Inc
  • Acacia Pharma Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cancer Anorexia-Cachexia Syndrome Drug Market by Type
  6. 1.3.1 NEO-1940
  7. 1.3.2 Foxo1-nRNA
  8. 1.3.3 DLN-101
  9. 1.3.4 C-1889
  10. 1.3.5 AVGN-7
  11. 1.3.6 Others
  12. 1.4 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Type
  13. 1.4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cancer Anorexia-Cachexia Syndrome Drug Industry Trends
  2. 2.2 Cancer Anorexia-Cachexia Syndrome Drug Industry Drivers
  3. 2.3 Cancer Anorexia-Cachexia Syndrome Drug Industry Opportunities and Challenges
  4. 2.4 Cancer Anorexia-Cachexia Syndrome Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cancer Anorexia-Cachexia Syndrome Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Cancer Anorexia-Cachexia Syndrome Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Cancer Anorexia-Cachexia Syndrome Drug Price (2021-2026)
  4. 3.4 Global Cancer Anorexia-Cachexia Syndrome Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Anorexia-Cachexia Syndrome Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Cancer Anorexia-Cachexia Syndrome Drug Company, Product Type & Application
  7. 3.7 Global Cancer Anorexia-Cachexia Syndrome Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Anorexia-Cachexia Syndrome Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Anorexia-Cachexia Syndrome Drug Tier 1, Tier 2, and Tier 3
4 Cancer Anorexia-Cachexia Syndrome Drug Regional Status and Outlook
  1. 4.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size by Region
  3. 4.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Region
  7. 4.3.1 Global Cancer Anorexia-Cachexia Syndrome Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cancer Anorexia-Cachexia Syndrome Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cancer Anorexia-Cachexia Syndrome Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cancer Anorexia-Cachexia Syndrome Drug by Application
  1. 5.1 Cancer Anorexia-Cachexia Syndrome Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size by Application
  6. 5.2.1 Global Cancer Anorexia-Cachexia Syndrome Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cancer Anorexia-Cachexia Syndrome Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cancer Anorexia-Cachexia Syndrome Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Viking Therapeutics Inc
  8. 6.2.1 Viking Therapeutics Inc Company Information
  9. 6.2.2 Viking Therapeutics Inc Business Overview
  10. 6.2.3 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Viking Therapeutics Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  12. 6.2.5 Viking Therapeutics Inc Recent Developments
  13. 6.3 RaQualia Pharma Inc
  14. 6.3.1 RaQualia Pharma Inc Company Information
  15. 6.3.2 RaQualia Pharma Inc Business Overview
  16. 6.3.3 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 RaQualia Pharma Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  18. 6.3.5 RaQualia Pharma Inc Recent Developments
  19. 6.4 PsiOxus Therapeutics Ltd
  20. 6.4.1 PsiOxus Therapeutics Ltd Company Information
  21. 6.4.2 PsiOxus Therapeutics Ltd Business Overview
  22. 6.4.3 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 PsiOxus Therapeutics Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  24. 6.4.5 PsiOxus Therapeutics Ltd Recent Developments
  25. 6.5 Obexia AG
  26. 6.5.1 Obexia AG Company Information
  27. 6.5.2 Obexia AG Business Overview
  28. 6.5.3 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Obexia AG Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  30. 6.5.5 Obexia AG Recent Developments
  31. 6.6 Lakewood-Amedex Inc
  32. 6.6.1 Lakewood-Amedex Inc Company Information
  33. 6.6.2 Lakewood-Amedex Inc Business Overview
  34. 6.6.3 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lakewood-Amedex Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  36. 6.6.5 Lakewood-Amedex Inc Recent Developments
  37. 6.7 Incyte Corp
  38. 6.7.1 Incyte Corp Company Information
  39. 6.7.2 Incyte Corp Business Overview
  40. 6.7.3 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Incyte Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  42. 6.7.5 Incyte Corp Recent Developments
  43. 6.8 Aphios Corp
  44. 6.8.1 Aphios Corp Company Information
  45. 6.8.2 Aphios Corp Business Overview
  46. 6.8.3 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aphios Corp Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  48. 6.8.5 Aphios Corp Recent Developments
  49. 6.9 Aeterna Zentaris Inc
  50. 6.9.1 Aeterna Zentaris Inc Company Information
  51. 6.9.2 Aeterna Zentaris Inc Business Overview
  52. 6.9.3 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aeterna Zentaris Inc Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  54. 6.9.5 Aeterna Zentaris Inc Recent Developments
  55. 6.10 Acacia Pharma Ltd
  56. 6.10.1 Acacia Pharma Ltd Company Information
  57. 6.10.2 Acacia Pharma Ltd Business Overview
  58. 6.10.3 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Acacia Pharma Ltd Cancer Anorexia-Cachexia Syndrome Drug Product Portfolio
  60. 6.10.5 Acacia Pharma Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
  2. 7.1.1 North America Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  6. 7.2.1 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
  2. 8.1.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  6. 8.2.1 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
  2. 9.1.1 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
  2. 10.1.1 South America Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  6. 10.2.1 South America Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country
  2. 11.1.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cancer Anorexia-Cachexia Syndrome Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cancer Anorexia-Cachexia Syndrome Drug Value Chain Analysis
  2. 12.1.1 Cancer Anorexia-Cachexia Syndrome Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cancer Anorexia-Cachexia Syndrome Drug Production Mode & Process
  7. 12.2 Cancer Anorexia-Cachexia Syndrome Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cancer Anorexia-Cachexia Syndrome Drug Distributors
  10. 12.2.3 Cancer Anorexia-Cachexia Syndrome Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst